ID23377A - Senyawa-senyawa diamina siklik dan obat-obatan yang mengandung senyawa tersebut - Google Patents

Senyawa-senyawa diamina siklik dan obat-obatan yang mengandung senyawa tersebut

Info

Publication number
ID23377A
ID23377A IDW991669A ID991669A ID23377A ID 23377 A ID23377 A ID 23377A ID W991669 A IDW991669 A ID W991669A ID 991669 A ID991669 A ID 991669A ID 23377 A ID23377 A ID 23377A
Authority
ID
Indonesia
Prior art keywords
optionally substituted
lower alkyl
alkyl group
integer
compound
Prior art date
Application number
IDW991669A
Other languages
English (en)
Indonesian (id)
Inventor
Kimiyuki Shibuya
Katsumi Kawamine
Yukihiro Sato
Toru Miura
Chiyoka Ozaki
Toshiyuki Edano
Mitsuteru Hirata
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of ID23377A publication Critical patent/ID23377A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70—Sulfur atoms
    • C07D277/74—Sulfur atoms substituted by carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDW991669A 1997-05-26 1998-05-26 Senyawa-senyawa diamina siklik dan obat-obatan yang mengandung senyawa tersebut ID23377A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14989297 1997-05-26

Publications (1)

Publication Number Publication Date
ID23377A true ID23377A (id) 2000-04-20

Family

ID=15484915

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991669A ID23377A (id) 1997-05-26 1998-05-26 Senyawa-senyawa diamina siklik dan obat-obatan yang mengandung senyawa tersebut

Country Status (19)

Country Link
EP (1) EP0987254B1 (de)
JP (1) JP3614865B2 (de)
KR (1) KR100549804B1 (de)
CN (1) CN1118457C (de)
AT (1) ATE285402T1 (de)
AU (1) AU728151B2 (de)
CA (1) CA2290744C (de)
CZ (1) CZ297451B6 (de)
DE (1) DE69828276T2 (de)
ES (1) ES2235328T3 (de)
HU (1) HUP0002294A3 (de)
ID (1) ID23377A (de)
NO (1) NO315045B1 (de)
NZ (1) NZ501156A (de)
PT (1) PT987254E (de)
RU (1) RU2207341C2 (de)
SK (1) SK284891B6 (de)
TW (1) TW589308B (de)
WO (1) WO1998054153A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
WO1999043659A1 (en) * 1998-02-25 1999-09-02 Sumitomo Pharmaceuticals Co., Ltd. Pyridone derivatives and process for producing the same
KR20020022728A (ko) * 1999-06-28 2002-03-27 무네유키 가코우 벤즈 이미다졸 화합물 및 그것을 함유하는 의약
ATE275560T1 (de) * 1999-06-30 2004-09-15 Fuji Photo Film Co Ltd Bemzimidazolverbindungen und medikamente die diese enthalten
WO2001004110A1 (en) * 1999-07-07 2001-01-18 Fuji Photo Film Co., Ltd. Benzimidazole compounds
JP4242765B2 (ja) * 2001-08-22 2009-03-25 興和株式会社 血管壁選択的なacat阻害剤
US20060165605A1 (en) * 2001-12-28 2006-07-27 Ye-Mon Chen Process to regenerate fcc spent catalyst
DK1566381T3 (da) 2002-11-28 2010-01-25 Kowa Co Fremgangsmåde til fremstilling af 1- 2-(benzimidazol-2-ylthio)ethyl-piperazin eller salte deraf
ATE365737T1 (de) * 2002-12-05 2007-07-15 Cv Therapeutics Inc Substituierte piperazinverbindungen undderen verwendung als fettsuureoxidationsinhibitoren
EP1571144A4 (de) 2002-12-12 2007-08-01 Kowa Co Hydroxyalkylierte cyclischediaminverbindung
MY140618A (en) * 2003-02-28 2009-12-31 Kowa Co Method for preparing acid addition salts of polyacidic basic compounds
WO2004099179A1 (en) * 2003-05-07 2004-11-18 Actelion Pharmaceuticals Ltd Piperazine-alkyl-ureido derivatives
JP4806566B2 (ja) * 2003-05-28 2011-11-02 興和株式会社 環状ジアミン誘導体又はその塩の製造法
TWI324600B (en) * 2003-07-07 2010-05-11 Kowa Co 2,4-bis (trifluoroethoxy) pyridine compound and drug containing the compound
KR20060111898A (ko) * 2003-08-29 2006-10-30 교와 가부시키가이샤 지질-풍부-플라크의 안정화 방법 및 파열 예방방법
EP2428516A1 (de) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Neue Phosphor enthaltende Thyromimetika
US7163944B2 (en) * 2004-01-26 2007-01-16 Kowa Co., Ltd. Cyclic diamine compound and pharmaceutical containing the same
JPWO2006003974A1 (ja) * 2004-06-30 2008-04-17 興和株式会社 環状ジアミン誘導体の製造法
CN101039652A (zh) * 2004-08-16 2007-09-19 宝洁公司 2-(氨基或取代的氨基)-5,6-取代的苯酚化合物,包含该化合物的染料组合物以及它们的应用
US7923573B2 (en) 2004-10-27 2011-04-12 Daiichi Sankyo Company, Limited Benzene compound having 2 or more substituents
TW200619204A (en) * 2004-12-10 2006-06-16 Kowa Co Method for reduction, stabilization and prevention of rupture of lipid rich plaque
FR2920769B1 (fr) 2007-09-06 2009-10-30 Galderma Res & Dev Nouveaux derives de n-phenyl acetamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant
FR2920770B1 (fr) * 2007-09-06 2009-10-30 Galderma Res & Dev Nouveaux derives de phenylurees, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant
FR2920774B1 (fr) * 2007-09-06 2009-10-30 Galderma Res & Dev Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
JP5291979B2 (ja) 2008-04-24 2013-09-18 株式会社フジクラ 圧力センサ及びその製造方法と、該圧力センサを備えた電子部品
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
CN102711762A (zh) * 2009-12-29 2012-10-03 兴和株式会社 口服用固体医药组合物
WO2011081118A1 (ja) 2009-12-29 2011-07-07 興和株式会社 経口投与用医薬組成物
US20130066075A1 (en) * 2010-05-19 2013-03-14 Kowa Company, Ltd. Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis
CN105579457B (zh) * 2013-03-20 2017-08-04 拜耳制药股份公司 取代的n‑联苯‑3‑乙酰基氨基‑苯甲酰胺和n‑[3‑(乙酰基氨基)苯基]‑联苯‑甲酰胺及其作为wnt信号通路抑制剂用途
CN105693524A (zh) * 2014-11-28 2016-06-22 浙江省化工研究院有限公司 一种硝基化合物的制备方法
WO2018097149A1 (ja) * 2016-11-24 2018-05-31 帝人ファーマ株式会社 スルフィド化合物の製造方法
AR121715A1 (es) 2020-04-03 2022-06-29 Biocryst Pharm Inc Pirrolopirimidinaminas como inhibidores del sistema del complemento

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629208A (en) * 1969-06-18 1971-12-21 Monsanto Co N-aminoalkyl thiazolesulfenamides as vulcanization accelerators
DD290192A5 (de) * 1986-11-13 1991-05-23 Eisai Co. Ltd,Jp Pyridinderivat mit antiulzeroeser wirkung
CA2003283A1 (en) * 1988-12-05 1990-06-05 C. Anne Higley Imidazoles for the treatment of atherosclerosis
WO1992007825A1 (fr) * 1990-11-05 1992-05-14 Taisho Pharmaceutical Co., Ltd. Derive de phenol
RU2036057C1 (ru) * 1991-01-25 1995-05-27 Александр Петрович Войнов Устройство для плющения зубьев пил
US5721266A (en) * 1993-05-28 1998-02-24 Warner-Lambert Company Substituted imidazolinyl-imidazolines as antagonists of SH-2 binding and therapeutic uses thereof
US5596001A (en) * 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
JP4191269B2 (ja) * 1996-05-17 2008-12-03 興和株式会社 新規なアニリド化合物及びこれを含有する医薬
JP4647726B2 (ja) * 1997-03-25 2011-03-09 興和株式会社 新規なアニリド化合物及びこれを含有する医薬
DE69834052T2 (de) * 1997-11-14 2006-11-02 Kowa Co., Ltd., Nagoya Neue amidverbindungen und medikamente die diese enthalten

Also Published As

Publication number Publication date
SK158299A3 (en) 2001-02-12
TW589308B (en) 2004-06-01
WO1998054153A1 (en) 1998-12-03
CN1258283A (zh) 2000-06-28
HUP0002294A3 (en) 2001-10-29
PT987254E (pt) 2005-04-29
RU2207341C2 (ru) 2003-06-27
ATE285402T1 (de) 2005-01-15
DE69828276D1 (de) 2005-01-27
EP0987254A1 (de) 2000-03-22
CZ415999A3 (cs) 2000-05-17
NO995783D0 (no) 1999-11-25
NO315045B1 (no) 2003-06-30
CA2290744C (en) 2009-12-22
NZ501156A (en) 2002-02-01
AU7451298A (en) 1998-12-30
NO995783L (no) 2000-01-26
KR20010012926A (ko) 2001-02-26
EP0987254A4 (de) 2000-09-13
ES2235328T3 (es) 2005-07-01
CZ297451B6 (cs) 2006-12-13
HUP0002294A2 (hu) 2001-09-28
AU728151B2 (en) 2001-01-04
CA2290744A1 (en) 1998-12-03
KR100549804B1 (ko) 2006-02-08
SK284891B6 (sk) 2006-02-02
EP0987254B1 (de) 2004-12-22
DE69828276T2 (de) 2005-12-15
CN1118457C (zh) 2003-08-20
JP3614865B2 (ja) 2005-01-26

Similar Documents

Publication Publication Date Title
NO995783L (no) Nye cykliske diaminforbindelser og medisiner inneholdende de samme
DE60232739D1 (de) Aktivator des peroxisomproliferator-aktivierten rezeptors delta
EP0287356A3 (en) Novel compounds
MY123337A (en) Oxyiminoalkanoic acid derivatives.
AU755654C (en) Novel amide compounds and drugs containing the same
DK0807627T3 (da) Anilidforbindelser som ACAT-inhibitorer
DE69937045D1 (de) Cyclische amidderivate
EP1306369A4 (de) Neue schwefelverbindungen und intermolekulare verbindungen, die diese als komponente enthalten
DE60239468D1 (de) Amphotere lipidverbindung und deren verwendung
FI913067A0 (fi) Bisfosfonsyraderivat, deras framstaellning och anvaendning.
DE69004598D1 (de) 6-Amino-6-desoxyfumagillole, ihre Herstellung und ihre Verwendung.
HUT66266A (en) Modified oligodeoxyribonucleotides, process for producing them, and pharmaceutical compositions containing them
DE69830600D1 (de) Anilidverbindungen und medikamente, die diese enthalten
ATE168679T1 (de) Neue tetracyclische verbindungen
ATE128131T1 (de) Substituierte pyridinsulfonamide oder deren salze, verfahren zur herstellung und diese enthaltende herbizide.
IL136510A (en) Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same
WO2003075928A3 (en) Stable pharmaceutical compositions
ATE291015T1 (de) Alkylaminoderivate
HUT59930A (en) Process for producing bis-phosphonic acid derivatives and pharmaceutical compositions containing them as active component
ATE222234T1 (de) Cyclische amic-säurederivate